References
- Tanner RM, Baber U, Carson AP, et al. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol 2011;108:227–232.
- Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrilation: Epidemiology, pathoph- ysiology and clinical outcomes. Circ Res 2017;120:1501-17.
- Nattel S, Harada M. Atrial remodeling and atrial fibrillation:recent advances and translational perspectives. J Am Coll Cardiol 2014;63:2335-45.
- Disertori M, Lombardi F, Barlera S, et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J 2011;162:382–9.
- Wu N, Xu B, Xiang Y, et al. Association of inflammatory factors with occurrence and recurrence with atrial fibrillation:a meTanalysis. Int J Cardiol 2013;169:62-72.
- Guo Y, Lip GY. Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60 (22):2263–70.
- Barassi A, Pezzilli R, Morselli-Labate AM, et al. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Can J Cardiol 2012;28(5):537-41.
- Tong Liu, Guangping Li, Lijian Li, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2006;12:042.
- Yo CH, Lee SH, Chang SS, Lee MC, Lee CC. Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis. BMJ Open 2014;20;4.
- Yu L, Jian Z, Tao L, Zongtao Y, Yan JJ, Han Z, et al. The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery. BMC Cardiovascular Disorder 2022;22(45).
- Hidrics G, Potparo T, Nikolaos D, Arbelo EJ, Bax J, Blomstron-Ludgvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. EHJ 2021;42(5):373-498.
- The seventh report of Joint National Committee on Prevention, Detection, Evaluation and treatment of Hight Blood Pressure. JAMA 2003;289:2550-72.
- America Diabetes Association. Standards for medical care for patient with diabetes mellitus. Diabetes Care 2002;25(Suppl 1):S33-S49.
- Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, and National Heart, Lung, and Blood Institute. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–45.
- Center for disease control/American Heart association Workshop on inflammatory Markers, and Cardiovascular Disease: Application to clinical and public health practice: Atalanta, March 14-15, 2002. Atlanta, Ga. Centers for Disease Control and Prevention: 2002.
- Lang RM, Badano LP, Mor-Avi, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Amer Soc Echocardio 2015;28(1):1–39.
- Gibson CM, Basto AN, Howard ML. Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence. Annals Pharmacotherapy 2018.
- Zarauza J, Rodriguez Lera MJ, Farinas Alvarez C, et al. Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion. Rev Esp Cardiol 2006;59:125-129.
- Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006;108:346-353.
- Wazni O, Martin DO, Marrouche NF, et al. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 2005;91:1303-1305.
- Korantzopoulos P, Kolettis TM, Kountouris E, Siogas K, Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation: Is there an association with early recurrence rates? Int J Clin Pract 2005;59:881-885.
- Cosgrave J, Foley JB, Bahadur K, Bennett K, Crean P, Walsh MJ. Inflammatory markers are not associated with outcomes following elective external cardioversion. Int J Cardiol 2006;110:373-377.
- Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010;121 (2):200–7.
- Jani Y, Haxhirexha K, Pocesta B, et al. Impact of Inflammation on Atrial Fibrillation in patients with Metabolic Syndrome. J Cardiology Interventions 2021;2(01):1-8.
- Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263–2270.
- Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180–4.
- Hadi AR, Alawi A, Wael AL & Jassim M. Inflammatory cytokines and atrial fibrillation: current and prospective views. Journal of Inflammation Research. 2010:75-97.
- Tieleman RG, Van Gelder IC, Crijns HGJM, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-173.
- Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Amer Coll Cardio 2014;63(22):2335–2345.
- Motoc A, Abugattas JP, Roosens B, Scheirlynck E, Heyndrickx B, de Asmundis C, et al. Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation. Cardiovascular Ultrasound 2018;25(19):16-19.
- Benditt DG, Williams JH, Jim J. Maintenance of sinus rhythm with oral d, l-sotalol therapy in patients with symptomatic atrial fibrillation and/or flutter. D, l-Sotalol Atrial Fibrillation/Flutter Group. Am J Cardiol 1999;84:270–277.
- Coplen SE, Antman EM, Berkis JA. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized trials. Circulation 1990;82:1106–1116.
- Letsas KP, Weber R, Burkle G, Mihas CC, Minners J, Kalusche D, Arentz T. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009;11(2):158–63.
- Panagiotis K, Konstantinos P, Letsas F, Gary T, Nikolaos F, et al. Inflammation and atrial fibrillation:Acomprehesive review. J Arrhyth 2018.
- Korantzopoulos P, Kolettis TM, Kountouris E, Siogas K, Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? Int J Clin Pract 2005 Aug;59(8):881-5.